Evidence map›Paper›PMID 32433026›Full record

ReviewDisease models & mechanisms2020

Membrane trafficking in health and disease.

Rebecca Yarwood, John Hellicar, Philip G Woodman, Martin Lowe

Open access · goldAbstract readReview
In one paragraph

Review in Disease models & mechanisms, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 76 papers.

0numbers the graph read from it
0cells of the map it votes in
76citing papers in PubMed
11.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

76 citing papers in PubMed, 157 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Endosomal TPC1-mediated CaProceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. The Neuronal Golgi Network and Its Acolytes.Sub-cellular biochemistry · 2026
    Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

16 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Rebecca YarwoodSchool of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, M13 9PT, UK.
John HellicarSchool of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, M13 9PT, UK.
Philip G WoodmanSchool of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, M13 9PT, UK philip.woodman@manchester.ac.uk martin.lowe@manchester.ac.uk.ORCID 0000-0001-9497-1235
Martin LoweSchool of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, M13 9PT, UK philip.woodman@manchester.ac.uk martin.lowe@manchester.ac.uk.ORCID 0000-0002-9331-8143
University of Manchester · GB

Funding

Biotechnology and Biological Sciences Research Council BB/R015864/1Biotechnology and Biological Sciences Research Council BB/S014799/1Biotechnology and Biological Sciences Research Council BB/T000945/1Wellcome TrustWellcome Trust 203995/Z/16/ZWellcome Trust 212246/Z/18/Z
6 · The paper itself

Abstract

Membrane trafficking pathways are essential for the viability and growth of cells, and play a major role in the interaction of cells with their environment. In this At a Glance article and accompanying poster, we outline the major cellular trafficking pathways and discuss how defects in the function of the molecular machinery that mediates this transport lead to various diseases in humans. We also briefly discuss possible therapeutic approaches that may be used in the future treatment of trafficking-based disorders.

Indexed as

DiseaseHealthAnimalsCell MembraneEndocytosisHumansSecretory PathwayDiseaseEndocytic pathwayGenetic disorderMembrane trafficSecretory pathwayVesicle

Identifiers

PMID32433026
PMCPMC7197876
OpenAlexW3023081687

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.